Share This Article:

Long-Term Impact in Hepatitis C Virus Infection in Post Renal Transplantation

Full-Text HTML Download Download as PDF (Size:157KB) PP. 9-13
DOI: 10.4236/ojots.2012.23003    3,644 Downloads   7,258 Views  

ABSTRACT

Purpose: The authors have evaluated the impact of the kidney transplantation associated with chronic hepatitis C virus (HCV) infection, analyzing the complications, patients and graft survival. Methods: Retrospective study with 40 kidney transplant recipients with HCV infection and 40 kidney transplant recipients without HCV infection in the same post transplantation period. Results: the average follow-up after transplantation was 12.3 ± 4.5 years in patients with HCV infection and 12.5 ± 2.9 years in patients without HCV infection (p = 0.49). There was no statistical difference related to age and gender of the recipient nor donor age and type. The current renal function in patients with HCV infection was 47.3 ± 24.9 mL/min and 54.9 ± 27.2 mL/min in the HCV negative group (p = 0.54). The incidence of graft and patient survival was similar in both groups. The main cause of death in both groups was bacterial infection (10% in patients with HCV infection and 12.5% in HCV negative patients (p = 0.63). The most common complication in the two groups were acute allograft rejection and bacterial infection. The incidence of diabetes mellitus did not differ statistically in both groups. Abnormal liver enzymes levels and cirrhosis were observed only in patients with HCV infection. Conclusion: HCV infection did not impact patient or graft survival and post-transplant complications were similar in both groups during a mean follow-up period of 12 years.

Cite this paper

Lasmar, E. , Lasmar, M. , Lasmar, L. , Nogueira, A. , Santos, M. , Giordano, L. and Vianna, H. (2012) Long-Term Impact in Hepatitis C Virus Infection in Post Renal Transplantation. Open Journal of Organ Transplant Surgery, 2, 9-13. doi: 10.4236/ojots.2012.23003.

References

[1] F. Fabrizi, F. F. Poodad and P. Martin, “Hepatitis C Infection and the Patient with End-Stage Renal Disease,” Hepatology, Vol. 36, No. 1, 2002, pp. 3-10. doi:10.1053/jhep.2002.34613
[2] G. G. Vosnides, “Hepatitis C in Renal Transplantation,” Kidney International, Vol. 52, No. 3, 1997, pp. 843-861. doi:10.1038/ki.1997.403
[3] B. J. Pereira and A. S. Levey, “Hepatitis C Virus Infection in Dialysis and Renal Transplantation,” Kidney International, Vol. 51, No. 4, 1997, pp. 981-999. doi:10.1038/ki.1997.139
[4] R. D. Bloom, G. Sayer, K. Fa, et al., “Outcome of Hepatitis C Virus-Infected Kidney Transplant Candidates Who Remain on the Waiting List,” American Journal of Transplantation, Vol. 5, No. 1, 2005, pp. 139-144. doi:10.1111/j.1600-6143.2004.00652.x
[5] A. Brüchfeld, H. Wilczek and C. G. Elinder, “Hepatitis C Virus Infection, Time in Renal Replacement Therapy, and Outcome after Kidney Transplantation,” Transplantation, Vol. 78, No. 5, 2004, pp. 745-750. doi:10.1097/01.TP.0000131948.29742.24
[6] C. O. Stehman-Breen, S. Emerson, D. Gretch, et al., “Rise of Death among Chronic Dialysis Patients Infected with Hepatitis C Virus,” American Journal of Kidney Diseases, Vol. 32, No. 3, 1998, pp. 629-634. doi:10.1016/S0272-6386(98)70027-7
[7] S. Sezer, F. N. Ozdemir, A. Akcay et al., “Renal Transplantation Offers a Better Survival in HCV Infected ESRD Patients,” Clinical Transplantation, Vol. 18, No. 5, 2004, pp. 619-623. doi:10.1111/j.1399-0012.2004.00252.x
[8] B. J. Pereira, “Hepatitis C Infection and Post-Transplantation Liver Disease,” Nephrology Dialysis Transplantation, Vol. 10, No. 1, 1995, pp. 58-67.
[9] B. J. Pereira, T. L. Wright, C. H. Schmid, et al., “The Impact of Pre-Transplantation Hepatitis C Infection on the Outcome of Renal Transplantation,” Transplantation, Vol. 60, No. 8, 1995, pp. 799-805.
[10] M. A. Gentil, J. L. Rocha, G. Rodrigues-Algarra, et al., “Impaired Kidney Transplant Survival in Patients with Antibodies to Hepatitis C Virus,” Nephrology Dialysis Transplantation, Vol. 14, No. 10, 1999, pp. 2453-2460. doi:10.1093/ndt/14.10.2455
[11] C. A. Stempel, J. Lake, G. Kuo, et al., “Hepatitis C Virus Infection and Renal Transplantation,” Transplantation, Vol. 55, No. 2, 1993, pp. 273-276. doi:10.1097/00007890-199302000-00008
[12] E. P. Lasmar, M. F. Lasmar, L. F. Lasmar, et al., “LongTerm Impact of Hepatitis C in Renal Transplant Recipients—Preliminary Data,” Jornal Brasileiro de Transplantes, Vol. 11, No. 2, 2008, pp. 915-917.
[13] G. M. Sahin, S. Sahin, G. Kantarcig and H. Ergin, “Impact of Hepatitis C Virus Infection on Patient and Graft Survival in Kidney Transplantation,” Transplantation Proceedings, Vol. 38, No. 2, 2006, pp. 499-501. doi:10.1016/j.transproceed.2006.01.007
[14] S. Pedroso, L. Martines, I. Fonseca, et al., “Impact of Hepatits C Virus on Renal Transplantation: Association with Poor Survival,” Transplantation Proceedings, Vol. 38, No. 6, 2006, pp. 1890-1894. doi:10.1016/j.transproceed.2006.06.065
[15] Corrêa Jr, F. D. Rocha, L. F. Gon?alves and R. C. Manfro, “Long Term Effect of Hepatitis B and C Virus on the Survival of Kidney Transplant Patients,” Revista da Associa??o Médica Brasileira, 2003, Vol. 49, No. 4, pp. 389-394.
[16] J. M. Morales and J. M. Campistol, “Transplantation in the Patient with Hepatitis C,” Journal of the American Society of Nephrology, Vol. 11, No. 7, 2000, pp. 13431353.
[17] C. H. Legendre, V. Garrigue, C. Le Bihan, et al., “Harmful Long-Term Impact of Hepatitis C Virus Infection in Kidney Transplant Recipients,” Transplantation, Vol. 65, No. 5, 1998, pp. 667-670. doi:10.1097/00007890-199803150-00011
[18] D. Roth, K. Zucker, R. Cirocco, et al., “The Impact of Hepatitis C Virus Infection on Renal Allograft Recipients,” Kidney International, Vol. 45, No. 1, 1994, pp. 238-244. doi:10.1038/ki.1994.29
[19] Y. Kokado and S. Takahara, “Ichimaru Netal: Clinical Outcome of HCV Infection after Renal Transplantation,” Transplantation Proceedings, Vol. 32, No. 7, 2000, pp. 1940-1943. doi:10.1016/S0041-1345(00)01503-7
[20] G. A. Knoll, M. R. Tankersle, L. Y. Lec, et al., “The Impact of Renal Transplantation on Survival in Hepatitis C Positive End-Stage Renal Disease Patients,” American Journal of Kidney Diseases, Vol. 29, No. 4, 1997, pp. 608-614. doi:10.1016/S0272-6386(97)90345-0
[21] J. M. Morales, B. Domingues-Gil, D. Sanz-Gajardo, et al., “The Influence of Hepatitis B and Hepatitis C Vírus Infection in the Recipient on Late Allograft Failure,” Nephrology Dialysis Transplantation, Vol. 19, No. 3, 2004, pp. 572-576.
[22] B. J. Pereira, et al., “Effects of Hepatitis C Infection and Renal Transplantation on Survival in End-Stage Renal Disease,” Kidney International, Vol. 53, No. 5, 1998, pp. 1374-1381. doi:10.1046/j.1523-1755.1998.00883.x
[23] W. C. Lee, K. H. Shu, C. H. Cheng, et al., “Long-Term Impact of Hepatitis B, C Virus Infection on Renal Transplantation,” American Journal of Nephrology, Vol. 21, No. 4, 2001, pp. 300-306. doi:10.1159/000046265
[24] J. M. Morales, “Renal Transplantation in Patients Positive for Hepatitis B or C,” Transplantation Proceedings, Vol. 30, No. 5, 1998, pp. 2064-2069. doi:10.1016/S0041-1345(98)00542-9
[25] G. G. Yosnides, “Hepatitis C in Renal Transplantation,” Kidney International, Vol. 52, No. 3, 1997, pp. 843-861. doi:10.1038/ki.1997.403
[26] A. Yildiz, Y. Tutuncu, H. Yazici, et al., “Association between Hepatitis C Virus Infection and Development of Post Transplantation Diabetes Mellitus in Renal Transplant Recipients,” Transplantation, Vol. 74, No. 8, 2002, pp. 1109-1113. doi:10.1097/00007890-200210270-00009
[27] A. Corell, J. M. Morales, A. Mandrono, et al., “Immunosuppression Induced by Hepatitis C Virus Infection Reduces Acute Renal Transplant Rejection,” The Lancet, Vol. 346, No. 8988, 1995, pp. 1497-1498. doi:10.1016/S0140-6736(95)92520-1
[28] G. Manga, S. Sahin, G. Kantarci, et al., “Impact of Hepatitis C Virus Infection on Patient and Graft Survival in Kidney Transplantation,” Transplantation Proceedings, Vol. 38, No. 2, 2006, pp. 499-501. doi:10.1016/j.transproceed.2006.01.007
[29] C. O. Stehman-Breenco, S. Emerson, D. Gretch, et al., “Rise of Death among Chronic Dialysis Patients Infected with Hepatitis C Virus,” American Journal of Kidney Diseases, Vol. 32, No. 4, 1998, pp. 629-634. doi:10.1016/S0272-6386(98)70027-7

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.